Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D round with participation from Koch ...
More than a quarter of Theranos’ blood analyzers were failing quality control after it started offering blood tests, threatening patients’ health, and company founder Elizabeth Holmes was told about ...
The use of machine learning to perform blood cell counts for diagnosis of disease instead of expensive and often less accurate cell analyzer machines has nevertheless been very labor-intensive as it ...
TEL AVIV, Israel--(BUSINESS WIRE)--Sight Diagnostics Ⓡ, the company behind the first FDA-cleared direct-from-fingerstick Complete Blood Count (CBC) analyzer, announced today it has raised $71 million ...
Inspira's AI-powered continuous blood monitoring technology demonstrated a high degree of accuracy in a key parameter, targeting multiple multi-billion-dollar market segments; Company plans to advance ...
The opportunity presented in fingerprick blood testing is one that many companies are chasing. Among these is Israeli diagnostics firm Sight Diagnostics, which announced Wednesday that the Food and ...
The use of machine learning to perform blood cell counts for diagnosis of disease instead of expensive and often less accurate cell analyzer machines has nevertheless been very labor-intensive as it ...
Once outside the body, stored blood begins degrading until, by day 42, they're no longer usable. Until now, assessing its quality has required laborious microscopic examination by human experts. A new ...
TEL AVIV, Israel--(BUSINESS WIRE)--Sight Diagnostics Ⓡ, the company behind the first FDA-cleared direct-from-fingerstick Complete Blood Count (CBC) analyzer, announced today it has raised $71 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results